Cassuto D, Cigni C, Bellia G, Schiraldi C
The therapeutic potential of VD-mediated GMBA modulation requires cautious interpretation, due to lack of VD status monitoring in donor/recipient animals and the absence of microbial metabolite profiling
Here, we mine a metabolomic dataset to assess TMAO levels in patients with diverse IEMs, including organic acidemias
The rate of weight loss on Semaglutide can vary depending on several individual factors including a patients starting weight, participation, and adherence to treatment, and lifestyle changes
Since then, they have been tested in hundreds of clinical trials and used by millions of people worldwide